| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Division of Respiratory Medicine (Dr. Chapman), Department of Medicine, University of Toronto, Toronto, Ontario, Canada; UCLA School of Medicine (Dr. Tashkin), Los Angeles, CA; and Westmount Research Consultants (Dr. Pye), Toronto, Ontario, Canada.
Correspondence to: Kenneth R. Chapman, MD, FCCP, Asthma Center of the University Health Network, Suite 4–011 ECW, 399 Bathurst St, Toronto, Ontario M5T 2S8, Canada; e-mail: kchapman{at}inforamp.net
Background: COPD is thought to be more prevalent among men than women, a finding usually attributed to higher smoking rates and more frequent occupational exposures of significance for men. However, smoking prevalence has increased among women and there is evidence that women may be more susceptible to the adverse pulmonary function effects of smoking than men. There may also be underdiagnosis and misdiagnosis of COPD in both sexes because objective measures of lung function are underused.
Objectives: We undertook the present study to determine if there is gender bias in the diagnosis of COPD, such that women are less likely than men to receive a diagnosis of COPD. We also attempted to determine if underuse of lung function measurements was a factor in any bias detected.
Methods: We surveyed a random sample of 192 primary-care physicians (96 American and 96 Canadian; 154 men and 38 women) using a hypothetical case presentation and a structured interview. The case of cough and dyspnea in a smoker was presented in six versions differing only in the age and sex of the patient. After presentation of the history and physical findings, physicians were asked to state the most probable diagnosis and to choose the diagnostic studies needed. Physicians were then presented with spirometric findings of moderate or severe obstruction without significant bronchodilator response, and the questions repeated. Finally, the negative outcome of an oral steroid trial was described.
Results: Initially, COPD was given as the most probable diagnosis significantly more often for men than women (58% vs 42%; p < 0.05). The likelihood of a COPD diagnosis increased significantly and initial differences between sexes decreased as objective information was provided. After spirometry, COPD diagnosis rates for men and women were 74% vs 66% (p = not significant); after the steroid trial 85% vs 79% (p = not significant). Only 22% of physicians would have requested spirometry after the initial presentation.
Conclusions: In North America, primary-care physicians underdiagnose COPD, particularly in women. Spirometry reduces the risk of underdiagnosis and gender bias but is underused.
Key Words: asthma • misdiagnosis • physician decision making • spirometry • underdiagnosis
This article has been cited by other articles:
|
|
 |
|
  M. K. Han, M. G. Kim, R. Mardon, P. Renner, S. Sullivan, G. B. Diette, and F. J. Martinez Spirometry Utilization for COPD: How Do We Measure Up? Chest, August 1, 2007; 132(2): 403 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. Jensen, N. S. Godtfredsen, P. Lange, and J. Vestbo Potential misclassification of causes of death from COPD Eur. Respir. J., October 1, 2006; 28(4): 781 - 785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jenkins Mars and Venus in the GP's office. Eur. Respir. J., August 1, 2006; 28(2): 259 - 261. [Full Text] [PDF]
|
|
|
|
|
|
W. M. Chatila, E. A. Hoffman, J. Gaughan, G. B. Robinswood, G. J. Criner, and for the National Emphysema Treatment Trial Researc Advanced emphysema in african-american and white patients: do differences exist? Chest, July 1, 2006; 130(1): 108 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. B. Soriano, G. T. Visick, H. Muellerova, N. Payvandi, and A. L. Hansell Patterns of Comorbidities in Newly Diagnosed COPD and Asthma in Primary Care Chest, October 1, 2005; 128(4): 2099 - 2107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Campos, A. Wanner, G. Zhang, and R. A. Sandhaus Trends in the Diagnosis of Symptomatic Patients With {alpha}1-Antitrypsin Deficiency Between 1968 and 2003 Chest, September 1, 2005; 128(3): 1179 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Vestbo COPD in the ECRHS Thorax, February 1, 2004; 59(2): 89 - 90. [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Celli A 62-Year-Old Woman With Chronic Obstructive Pulmonary Disease JAMA, November 26, 2003; 290(20): 2721 - 2729. [Full Text] [PDF]
|
|
|
|
|
|
J. B. Soriano, K. J. Davis, B. Coleman, G. Visick, D. Mannino, and N. B. Pride The Proportional Venn Diagram of Obstructive Lung Disease: Two Approximations From the United States and the United Kingdom Chest, August 1, 2003; 124(2): 474 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.T. Weiss, D.L. DeMeo, and D.S. Postma COPD: problems in diagnosis and measurement Eur. Respir. J., June 1, 2003; 21(41_suppl): 4S - 12s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sinvhal, L. Tosiello, G. Cable, R. I. Harik-Khan, J. L. Fleg, and R. A. Wise Confounding Issues in COPD Risk Study? Chest, January 1, 2003; 123(1): 307 - 308. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Singh, V. A. Palda, M. B. Stanbrook, and K. R. Chapman Corticosteroid Therapy for Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review Arch Intern Med, December 9, 2002; 162(22): 2527 - 2536. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Barr, J. Herbstman, F. E. Speizer, and C. A. Camargo Jr. Validation of Self-reported Chronic Obstructive Pulmonary Disease in a Cohort Study of Nurses Am. J. Epidemiol., May 15, 2002; 155(10): 965 - 971. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
